Meet Huddinge and Fabege in Almedalen

Now is the time for this year’s Almedal week. Don’t miss Fabege and Huddinge municipality’s events with a focus on sustainable urban development.

Thursday 29 juni
16:15 – 17:00
Local communities that last over time
How do we create long-term sustainable and integrated communities with today’s urban development and what role does the infrastructure play in development?
Organizer: Fabege AB, Huddinge kommun
Place: Donnersgatan 2, Wisby Strand Congress & Event, “Lokal: Lojsta”

Friday 30 june
14:30 – 15:30
Recipes for success for local communities that attract
How can the municipality, culture and business work together to create socially strong communities?
Organizer: Fabege AB, Huddinge kommun
Place: Donnersgatan 2, Wisby Strand Congress & Event, “Lokal: Lojsta”

Limitless Potential: Winner of the Flemingsberg Science Award 2025

Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.

It’s official – Alfa Laval has opened its new premises in Flemingsberg!

The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.

50 years of life-changing therapies

On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.